 Good evening, ladies and gentlemen. I think so far everyone's heard so many great research. So my name is Cindy Lin and I work at the Brain and Mind Center that belongs to the Sydney University. So first, what an honor to be here tonight to receive this award. I have received this award in 2007, 12 years ago. And now I want you to take a break and just imagine being relatively healthy and normal and then soon after you reach your adulthood, you slowly become weak and progressively not able to walk, talk, or swallow properly. So clearly there's a lot of neurodegenerative disease that share these symptoms. And these are the problems that are affected by patients with Kennedy's disease. It has, the Kennedy's disease was first published and described by Dr. William Kennedy, who's a neurologist in from United States and in 1968. So just two years older than the Brain Foundation, which was started in 1970. So it is known, it's also known as the X-link spinal and bulbous muscular atrophy. However, it's extremely rare, one in 40,000. That's why I inherited neurodegenerative disorder. However, it caused a very slow, progressive weakness and wasting of the muscle and affects the nerve that controls breathing, swallowing, and talking. Therefore, as you can understand how Brain Foundation has branches horizon that this Kennedy's disease is not on the cloud. So now I'm adding that into the Brain Foundation avenue. Okay, so by knowing this disease onset can actually range from as young as 18s to 64 years old. However, the diagnosis of confirmation can be delayed up to five years, because it's extremely rare and extremely difficult to diagnose. That's why our project is actually designed to address this issue by establishing a comprehensive central, meaning using functional MRI and peripheral assessments to investigate this disease. So the funding will provide us to basically to the fees of feeding these extremely rare patients to do the MRI scans, as well as assessing their peripheral nerve function, because neurodegeneration can occur from the brain, the spinal level all the way down to peripheral nerve. So our team, over 20 years of experience in neurodegenerative disorder, I would like to take on this project that will be able to comprehensively assess this patient. So I would like to take this opportunity to thank all the sponsors for your generosity and continuous support for the Brain Foundation, such that we have the foundation to further very important research. And finally, I would like to acknowledge my co-investigators, Dr. Susanna Park, Dr. Zanuja, Demata Asai, who's currently in Oxford, and my family, and we are all big family, especially to my husband, who's here tonight. Thank you very much.